These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8890251)

  • 1. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ; Briles DE; Volanakis JE
    Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.
    Singh SK; Ngwa DN; Agrawal A
    Front Immunol; 2020; 11():1812. PubMed ID: 32903624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.
    Suresh MV; Singh SK; Ferguson DA; Agrawal A
    J Immunol; 2006 Apr; 176(7):4369-74. PubMed ID: 16547275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.
    Suresh MV; Singh SK; Ferguson DA; Agrawal A
    J Immunol; 2007 Jan; 178(2):1158-1163. PubMed ID: 17202380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.
    Ngwa DN; Singh SK; Gang TB; Agrawal A
    Front Immunol; 2020; 11():586669. PubMed ID: 33117400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component.
    Szalai AJ; van Ginkel FW; Wang Y; McGhee JR; Volanakis JE
    J Immunol; 2000 Jul; 165(2):1030-5. PubMed ID: 10878380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of complement in the development of experimental pneumococcal pneumonia in mice.
    Nakajima R; Namba K; Ishida Y; Une T; Osada Y
    Chemotherapy; 1990; 36(4):287-93. PubMed ID: 2147644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.
    Alcantara RB; Preheim LC; Gentry-Nielsen MJ
    Infect Immun; 2001 Jun; 69(6):3569-75. PubMed ID: 11349015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
    Gang TB; Hanley GA; Agrawal A
    Infect Immun; 2015 May; 83(5):1845-52. PubMed ID: 25690104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.
    Gang TB; Hammond DJ; Singh SK; Ferguson DA; Mishra VK; Agrawal A
    J Biol Chem; 2012 Dec; 287(51):43116-25. PubMed ID: 23139417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.
    Szalai AJ; Briles DE; Volanakis JE
    J Immunol; 1995 Sep; 155(5):2557-63. PubMed ID: 7650385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein is essential for innate resistance to pneumococcal infection.
    Simons JP; Loeffler JM; Al-Shawi R; Ellmerich S; Hutchinson WL; Tennent GA; Petrie A; Raynes JG; de Souza JB; Lawrence RA; Read KD; Pepys MB
    Immunology; 2014 Jul; 142(3):414-20. PubMed ID: 24673624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.
    Ngwa DN; Singh SK; Agrawal A
    Front Immunol; 2020; 11():620784. PubMed ID: 33552084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2.
    Tong HH; Li YX; Stahl GL; Thurman JM
    Infect Immun; 2010 Mar; 78(3):976-83. PubMed ID: 20065024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
    Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ
    J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.
    Nakayama S; Gewurz H; Holzer T; Du Clos TW; Mold C
    Clin Exp Immunol; 1983 Nov; 54(2):319-26. PubMed ID: 6652963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.
    Ngwa DN; Agrawal A
    Front Immunol; 2019; 10():166. PubMed ID: 30863393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice.
    Wang E; Ouellet N; Simard M; Fillion I; Bergeron Y; Beauchamp D; Bergeron MG
    Infect Immun; 2001 Sep; 69(9):5294-304. PubMed ID: 11500398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.